Cytomegalovirus UL97 Kinase Mutations That Confer Maribavir Resistance

Authors:

Abstract
The cytomegalovirus (CMV) UL97 kinase inhibitor maribavir (MBV) is undergoing clinical antiviral trials. Two clinical CMV isolates serially passaged